WhatsApp
backNews Article

Emcure Pharmaceuticals to Participate in JM Financial Annual India Conference on November 16, 2026

Company officials to meet analysts and investors in Mumbai without sharing unpublished price sensitive information

Emcure Pharmaceuticals Limited announced its participation in the JM Financial Annual India Conference - India Xchange 2026, scheduled for November 16, 2026, in Mumbai. The company will engage with analysts and investors physically, with no unpublished price sensitive information to be shared during the meeting.

06 Nov 2026|EMCURE+0.70%
Emcure Pharmaceuticals LimitedEMCUREGeneral / Other

Emcure Pharmaceuticals Limited

General / Other

Emcure Pharmaceuticals Limited has scheduled its participation in the JM Financial Annual India Conference - India Xchange 2026 on November 16, 2026, in Mumbai, offering a platform for engagement with analysts and investors.

The event will be held physically in Mumbai, where Emcure Pharmaceuticals' officials will meet with industry analysts and investors.

The company confirmed that no unpublished price sensitive information will be shared during this meeting, maintaining compliance with regulatory requirements.

The schedule is tentative and subject to change due to exigencies by either the company or investors.

Highlights

  • Investor meeting set for November 16, 2026, in Mumbai at the JM Financial Annual India Conference.
  • Physical mode of interaction planned with analysts and investors.
  • No unpublished price sensitive information will be disclosed during the meeting.
  • Schedule may change depending on circumstances involving company or investors.

Key Data Snapshot

EventJM Financial Annual India Conference - India Xchange 2026
Date of MeetingNovember 16, 2026
LocationMumbai
ModePhysical
CompanyEmcure Pharmaceuticals Limited

What happened

  • Emcure Pharmaceuticals announced its planned participation in the JM Financial Annual India Conference scheduled for November 16, 2026.
  • The participation involves meetings with analysts and investors.
  • The meeting will be held in Mumbai in physical format.

Key details

  • No unpublished price sensitive information will be shared at the meeting.
  • The schedule is tentative and may change due to exigencies on the company or investor side.
  • The event provides an opportunity for direct engagement with financial analysts and institutional investors.

Regulatory and governance context

  • The disclosure is made pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Emcure Pharmaceuticals confirms compliance by not sharing any unpublished price sensitive information during the investor interactions.

More News on General / Other

View all

Latest corporate announcements and market updates in General / Other.

View all news
Emcure Pharmaceuticals to Participate in JM Financial | Stockk News